Cell adhesion molecule CD171 (L1) expression is also associated with tumour progression and poor prognosis in CRC patients [99,228], and has been used, in combination with E-cadherin and membranous β-catenin, to identify stage II patients who may benefit from adjuvant chemotherapy [104]. The gene discussed is CDH1; the disease is neoplasm.